Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.

Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.

Contact SupportLog In

agamatrix and amenarini cover image

Posted in: Glucose Monitoring Apr 05 | 2019CGM: WaveForm and A. Menarini Form Partnership for Ex-US Distribution Purchase Blast

sanofi cover image

Posted in: Bolus Insulin Apr 05 | 2019Sanofi Pursuing U200 Lispro; New Ph1 Study Purchase Blast

liveongo cover image

Posted in: Glucose Monitoring Apr 04 | 2019Livongo for Diabetes Integration with Amazon Alexa Purchase Blast

sanofi cover image

Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Apr 04 | 2019Sanofi To Layoff Diabetes Sales Reps; Details Remain Scarce Purchase Blast

cigna and express scripts cover image

Posted in: Basal Insulin, Bolus Insulin Apr 03 | 2019New Cigna/ESI Insulin Savings Program Introduced Ahead of Congressional Hearing Purchase Blast

lilly cover image

Posted in: Bolus Insulin Mar 28 | 2019Thoughts on Lilly Drug Pricing Transparency Purchase Blast

janssen cover image

Posted in: SGLT2i Mar 28 | 2019CREDENCE sNDA Filed; Priority Review Unclear Purchase Blast

dario health and glytec cover image

Posted in: Glucose Monitoring, Insulin Delivery Mar 27 | 2019Glytec Partners with Dario For Outpatient Insulin Titration Purchase Blast

cellnovo cover image

Posted in: Insulin Delivery Mar 26 | 2019Cellnovo to Close Operations?Purchase Blast

diamyd medical cover image

Posted in: Other Mar 26 | 2019Diamyd T1DM Vaccine Development Update Purchase Blast

astrazeneca cover image

Posted in: SGLT2i Mar 25 | 2019Forxiga T1DM Approved in Europe; Sota EU T1DM Approval Imminent Purchase Blast

lexicon and sanofi cover image

Posted in: SGLT2i Mar 22 | 2019Sotagliflozin T1DM Receives CRL From FDA Purchase Blast

OPKO cover image

Posted in: Dual/triple agonist Mar 21 | 2019OPKO Oxyntomodulin Ph2 Data; Is It Commercially Viable?Purchase Blast

lilly cover image

Posted in: Dual/triple agonist Mar 21 | 2019New Lilly Tirzepatide vs. Tresiba Ph3 Pivotal Study (SURPASS-3)Purchase Blast

novo cover image

Posted in: GLP-1RA Mar 20 | 2019Thoughts on Oral Sema and Ozempic Filings; 3 NDAs to De-risk Regulatory Uncertainty Purchase Blast

proventionbio cover image

Posted in: Other Mar 19 | 2019New T1DM Teplizumab Pivotal Ph3 trial (PROTECT)Purchase Blast

$fractyl cover image$

Posted in: Other Mar 18 | 2019Fractyl Hires Former Sanofi and Intercept VPs Purchase Blast

novo cover image

Posted in: GLP-1RA Mar 18 | 2019Novo-Teva Generic Victoza Settled; Launch Date Rationale Unclear Purchase Blast

sanofi cover image

Posted in: Bolus Insulin Mar 15 | 2019Potential Sanofi Bs-Aspart US Regulatory Strategy; New Interchangeability Trial Purchase Blast

lexicon cover image

Posted in: SGLT2i Mar 13 | 2019Lexicon Quiet on Sota T1DM Review; Q4 '18 Earnings Update Purchase Blast

« prev 1 … 78 79 80 81 82 … 99 next »